Medicine Overview of CTD-O Tablet
Nausea, Altered taste, Diarrhoea, Stomach upset, Weakness, Headache, Dizziness, Increased blood uric acid, Increased blood lipid level, Electrolyte imbalance, Glucose intolerance, Decreased blood pressure.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. CTD-O 12.5/20 Tablet is to be taken with food.
CTD-O 12.5/20 Tablet is a combination of two medicines: Olmesartan and chlorthalidone which lower blood pressure effectively. Olmesartan is an angiotensin receptor blocker (ARB). It works by blocking the hormone angiotensin thereby relaxing blood vessels. This allows the blood to flow more smoothly and the heart to pump more efficiently. Chlorthalidone is a diuretic that removes extra water and certain electrolytes from the body. Over time it also relaxes blood vessels and improves blood flow.
In Depth Information on CTD-O Tablet
- You have been prescribed CTD-O 12.5/20 Tablet for the treatment of high blood pressure. It decreases the risk of stroke and heart attacks.
It can be taken with or without food.
CTD-O 12.5/20 Tablet may cause dehydration. Drink plenty of fluids and Inform your doctor if you develop extreme thirst, muscle weakness or very dry mouth.
- It may cause dizziness. Get up slowly when rising from a sitting or lying position.
- CTD-O 12.5/20 Tablet is not safe to use if you're pregnant or breastfeeding.
CTD-O Tablet related warnings
Taking Chlorthalidone with alcohol may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.
WEIGH RISKS VS BENEFITS
CTD-O 12.5/20 Tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
CTD-O 12.5/20 Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
CTD-O 12.5/20 Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
CTD-O 12.5/20 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of CTD-O 12.5/20 Tablet may be needed. Please consult your doctor.
Use of CTD-O 12.5/20 Tablet is not recommended in these patients.
CTD-O 12.5/20 Tablet should be used with caution in patients with liver disease. Dose adjustment of CTD-O 12.5/20 Tablet may be needed. Please consult your doctor.
Use of CTD-O 12.5/20 Tablet is not recommended in patients with severe liver disease.
One of the following vendor pharmacies will deliver CTD-O 12.5/20 Tablet: DHR, BBN, KHH, HPC, BDN, GPT, SWP, OHM, ENP, MMS, TSS, HSP, AYM, BLE, SCH, JIV, 9MM, TFP, SVS, USF, LMS, PVP, BBS, BLS, SDM, DLP, SMN, PRT, GTK, UBL, PWN, BGS, NDP, NNH, KAL, SHC, BLP, AAY, MAX, KMC, AVS, SGH, CLT, MAP, ZPR, BHP, BAP, SLN, MDO, VRS, QTM, SRG, AMR, ATL, UMP, WSI, CHP, RPI, TNH, RSS, BIO, PRN, DGN, VDH, 9T9, LHA, AWS, OWP, HGI, DPL, ZEL, OLT, BAL, PEN, AGT, NTB, PLT, MPC, JHC, RDR, DAO, NVY, RKS, FGH, HEX, NNP, BTM, BMJ, BHM, ABP, EMB, BSN, GNC, ARD, PTI, GHR, THP, DHP, PPR, IAD, DYG, GBL, PNT, RDH, IPL, RJH, 4IT, ADT, JVN, HMP, JBT, LCC, PMA, HZF, GTC, SVH, NSL, KIS, MAM, SYN, HAT, EPS, OIP, HNP, PHN, DVH, EAN, STA, NVL, DPP, RHL, HTS, MLC, BHS, MBP, MAK, SWT, BNA, KHC, ATP, MKT, SSA, AYU, ANT, TRP, SAF, ANP, VJS, SGC, ZVP, HBV, SWA, KNH, MSD, RHW, JVO, SJP, BHA, NAS, ESY, RWP, WHL, RPP, JSL, DZY, QLF, HIP, DFP, RSA, SBA, EQN, AAR, TOM, GPP, SBL, EVP, SPD, SHD, UHP, MDH, VNS, RUS, NXG